Not provided
Not provided
Not provided
Not provided
Not provided
PI decision was made to discontinue the study
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the need to use the 19 gauge needle for core tissue procurement.
Inclusion Criteria
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 19 gauge | Active Comparator | Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle. |
|
| 22 gauge | Active Comparator | Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 19 gauge | Procedure | Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle |
|
| Measure | Description | Time Frame |
|---|---|---|
| 22 gauge needle | Compare the quality of core tissue specimens obtained between a 19G and 22G needle by evaluating the ability to perform molecular marker studies or immunohistochemistry studies between samples obtained. | 72 hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Shyam Varadarajulu, MD | AdventHealth | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Florida Hospital | Orlando | Florida | 32803 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010190 | Pancreatic Neoplasms |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004701 | Endocrine Gland Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 22 gauge | Procedure | Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle |
|
| D004066 |
| Digestive System Diseases |
| D010182 | Pancreatic Diseases |
| D004700 | Endocrine System Diseases |